vimarsana.com

Page 41 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pentagon says US has dropped to 2,500 troops in Afghanistan

State of California Extends and Expands Contract With Beam Global for Rapidly Deployed

Press release content from Globe Newswire. The AP news staff was not involved in its creation. State of California Extends and Expands Contract With Beam Global for Rapidly Deployed . Beam GlobalJanuary 14, 2021 GMT SAN DIEGO, Jan. 14, 2021 (GLOBE NEWSWIRE) Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable technology for electric vehicle (EV) charging, outdoor media and energy security, announced that the State of California has extended Beam Global’s contract #1-18-61-16 to supply EV ARC™ systems to State of California Departments and other governmental entities, and expanded the contract to include government entities in other U.S. states at the California negotiated price, without their having to go through a lengthy procurement or technology review process. The award extends the contract through June 23, 2022.

Altair International Completes First Stage of Lithium and Rare Earth Project Earn-In With

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Altair International Completes First Stage of Lithium and Rare Earth Project Earn-In With . Altair International Corp.January 14, 2021 GMT PITTSBURGH, Jan. 14, 2021 (GLOBE NEWSWIRE) Altair International Corp. (the “Company” or “Altair”) (OTC: ATAO) is pleased to announce that it has completed its Initial Earn-in Option as defined in the definitive agreement (the “Agreement”) with American Lithium Minerals, Inc. (“American Lithium”), a Nevada-based corporation. In seeking to purposefully position itself into the growing Lithium battery market, the Company signed the Agreement on November 24th 2020 with American Lithium that allows Altair the exclusive right to earn in up to a Sixty Percent (60%) interest in two projects, the Stonewall Lithium Project in southwestern Nevada and the Kingman Rare Earth Project in northwestern Arizona. The Earn-in agreement is granted to L

Eos Energy Enterprises Begins 2021 Propelled by Strong Demand for Energy Storage building a

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Eos Energy Enterprises Begins 2021 Propelled by Strong Demand for Energy Storage building a . Eos Energy Enterprises, Inc.January 13, 2021 GMT EDISON, N.J., Jan. 13, 2021 (GLOBE NEWSWIRE) Eos Energy Enterprises, Inc. ( NASDAQ: EOSE ) (“Eos”), a leading provider of safe, scalable, efficient, and sustainable zinc-based energy storage systems, today announced strong sales momentum over the past 90 days towards meeting its 2021 growth objectives. As of December 31, 2020, Eos logged $16 million of booked orders. Additionally, the company secured firm commitments supported by customer technical sections and letters of intent for an additional $550 million with expected delivery over the next three years. Eos entered binding agreements with a variety of top energy companies, including utilities and microgrid developers, to provide long-duration energy storage for multiple customer use c

Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel Kamada Ltd.January 13, 2021 GMT The Three Products Are Expected to Be Launched, Subject to Israeli Ministry of Health Approval, Between 2022 and 2024 Potential Collective Maximum Sales of the Three Products in the Israeli Market is Estimated at $5-$7 Million Annually These Sales Are i n Addition to the Potential $20-$30 Million from the Recently Licensed Alvotech Biosimilar Portfolio REHOVOT, Israel, Jan. 13, 2021 (GLOBE NEWSWIRE) Kamada Ltd. (Nasdaq: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that the Company has entered into agreements with two undisclosed international pharmaceutical companies to commercialize three biosimilar product candidates in Israel. Subject to approval by the European Medicines Agency (EMA) and subsequently by the Israel

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.